Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-07-23 Marshall Randall 10% owner Sale −1,950 $26.58 $52K 641,341
2020-07-23 Marshall Randall 10% owner Sale −93 $27.29 $3K 641,248
2020-07-22 Marshall Randall 10% owner Sale −1,297 $26.69 $35K 643,366
2020-07-22 Marshall Randall 10% owner Sale −75 $27.45 $2K 643,291
2020-07-21 Marshall Randall 10% owner Sale −223 $26.56 $6K 644,663
2020-07-20 Marshall Randall 10% owner Sale −2,257 $26.70 $60K 645,358
2020-07-20 Marshall Randall 10% owner Sale −472 $27.68 $13K 644,886
2020-07-17 Marshall Randall 10% owner Sale −1,601 $26.66 $43K 647,615
2020-07-13 Marshall Randall 10% owner Sale −2,145 $27.13 $58K 649,216
2020-07-10 Marshall Randall 10% owner Sale −2,659 $27.41 $73K 651,361
2020-07-10 Shefferman Jesse CEO and President Grant or award · Stock Option (Right to Buy) +111,250 111,250
2020-06-09 Levy Richard S Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-06-09 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-06-09 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-06-09 GARCEAU ROGER Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-06-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-06-09 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-02-11 Davis Blaine Chief Financial Officer Grant or award · Stock Option (Right to Buy) +94,000 94,000
2020-01-10 Solomon Michael Edward Director Grant or award +26,500 26,500
2020-01-10 Shefferman Jesse CEO and President Grant or award · Stock Option (Right to Buy) +111,250 111,250

Page 15 of 17 · 335 trades